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Medicine and the Community
A SUBSTANTIAL NUMBER of people
experience medication-related prob-
lems.1,2 Australian studies1,3 have shown
that closer collaboration between gen-
eral practitioners and pharmacists,
together with better medication review
by pharmacists,2 c n help to identify and
resolve many of these problems.
In its 1999 Budget, the Federal Gov-
ernment allocated funding for the provi-
sion of Home Medication Reviews
(HMRs). The Department of Health
and Aged Care (now the Department of
Health and Ageing) called for research
proposals to establish a model for imple-
menting these services.4 Our project
aimed to design and test a collaborative
model for delivering and evaluating
HMRs. We report the results of an
implementation trial in which we set out
to determine the requirements for and




We used a participatory action research
design,5 in which researchers worked
with participants to design, implement
and evaluate the service, allowing
researchers and participants to solve
problems that arose as the research pro-
gressed. The participatory action
research process involved general practi-
tioners, pharmacists and consumers in a
series of workshops, focus groups and
feedback sessions.
A call for expressions of interest in
participating in the project was sent to
all Divisions of General Practice in
South Australia. Eight of the 15 Divi-
sions responded and six participated
(three rural and three urban Divisions).
A Divisional Liaison Officer (DLO) was
employed in each Division to facilitate
the interaction between GPs and phar-
macists and to assist in the local imple-
mentation of the HMR service.
A collaborative service delivery model
(Box 1) was agreed on, and standard
forms for documenting relevant patient
information, reports and action plans
were developed in consultation with
participating GPs and pharmacists.
Implementing the service
The study was carried out between
March 1999 and March 2000.
GP and pharmacist recruitment
DLOs used divisional newsletters and
meetings with GPs to encourage partic-
ipation. Pharmacists were invited to
participate through a mailout. The
DLO visited interested GPs and com-
munity pharmacists to discuss the pro-
posed service, and provided support to
GPs and pharmacists throughout the
project. Local reference groups were
established to help resolve issues that
arose during implementation.
Patient selection and recruitment
Each GP or pharmacist identified 5–10
eligible patients from their practices,
based on patient selection criteria that
had been previously used to identify
patients at risk of having medication-
related problems (Box 2). GPs were eligi-
ble for RACGP clinical audit points if 10
of their patients participated in the study.
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ABSTRACT
Objective:  To implement and evaluate a collaborative medication management 
service model.
Design:  Participatory action research.
Setting and participants:  The study was conducted from March 1999 to March 
2000; 1000 patients, 63 pharmacists and 129 general practitioners from six 
Divisions of General Practice in South Australia participated.
Interventions:  A collaborative service delivery model, involving a preliminary case 
conference, a home visit and a second case conference, was agreed through 
discussions with medical and pharmacy organisations and then implemented.
Outcome measures:  Medication-related problems; actions recommended; actions 
implemented; and outcomes after actions taken.
Results:  Overall, 2764 problems were identified. The most common medication-
related problem (17.5% of all problems) was the need for additional tests. Thirty-
seven per cent of problems related to medicine selection, 20% to patient knowledge, 
and 17% to the medication regimen. Of 2764 actions recommended to resolve 
medication-related problems, 42% were implemented. Of the 978 problems for 
which action was taken and follow-up data were available, 81% were reported to 
be “resolved”, “well managed” or “improving”.
Conclusion:  This implementation model was successful in engaging GPs and 
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pharmacists and in assisting in the resolution of medication-related problems.
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For any patient identified by a com-
munity pharmacist, the pharmacist con-
sulted the patient’s GP to ensure the
patient met eligibility criteria. Verbal
consent for participation in the study
was sought from each patient and
recorded by the GP in the patient’s case
notes.
The medication management service
Once patients had agreed to participate,
a brief case conference was held
between the patient’s GP and the com-
munity pharmacist. Relevant informa-
tion was shared regarding the reason for
referral, current medical conditions,
prescribed medications and relevant
laboratory results.
Pharmacists visited each patient in
the home to discuss medication-related
issues raised by the patient or the
patient’s GP. The pharmacist recorded
information about all medications (pre-
scription and non-prescription) the
patient was taking, how they were being
taken, and how well the patient under-
stood the medications and their effect.
Administration devices were inspected
and the patient was asked to demon-
strate their use. Pharmacists clarified
dosing instructions, provided patient
education and assisted with dose
administration where required. Phar-
macists prepared a written report of the
home visit on a standard form.
The patient’s usual community phar-
macist conducted most home visits. As
many of the pharmacists had not previ-
ously undertaken this style of practice, a
hospital-based clinical pharmacist
reviewed the community pharmacists’
analyses and provided clinical advice
where necessary.
The GP and pharmacist met again to
discuss the reports and agree on a plan
of action to resolve outstanding medica-
tion-related problems within an appro-
priate time frame. Patients were
followed up, usually within three
months. The GP and pharmacist kept
case notes.
Evaluating the service
Two researchers coded the medical con-
ditions, medications taken and medica-
tion-related problems from patient case
notes. Medical conditions were catego-
rised according to the International clas-
sification of diseases (ICD-9-CM),6
medications according to the Anatomi-
cal and therapeutic classification7 and
medication-related problems according
to previously employed criteria (Box
3).1,3,8 From patient case notes, the
researchers noted actions taken to
address the problems (Box 4) and out-
comes of those actions (Box 5). For
some patients, the GP and pharmacist
identified more than one problem.
Ethics approval
The study was approved by the Human
Research Ethics Committee of the Uni-
versity of South Australia and the





A total of 129 GPs and 63 pharmacists
(representing 17% of GPs and 30% of
pharmacists in the six Divisions of Gen-
eral Practice) participated in the trial.
The target of 1000 patients was
achieved.
The median age of patients was 72
years for men (range, 1–100 years) and
74 years for women (range, 8–100
years). Fifty-three percent of the
patients lived in urban areas. The aver-
age number of medications being taken
was nine per patient (range, 2–25), and
the average number of medical condi-
tions per patient was 6 (range, 1–15).
1: Collaborative medication management model used in our study
Pharmacist and general practitioner meet to discuss the service and how they will work together
Pharmacist, community nurse or carer
identifies person at risk of medication
misadventure and contacts GP
GP identifies patient at risk of
medication misadventure and contacts
patient's pharmacist
GP seeks patient's consent, if patient meets selection criteria
Patient agrees to the service
Brief case conference between GP and pharmacist
Pharmacist makes appointment with patient and conducts home visit
Pharmacist consults with hospital (mentor) pharmacist re findings and prepares report
Second case conference between GP and pharmacist to discuss report and agree on plan of action
Pharmacist follows up patient and keeps case notes GP follows up patient and keeps case notes
2: Selection criteria for patient 
participants1
Patients included those who were
■ taking multiple medications;
■ taking 12 or more doses of medication a 
day;
■ taking high doses of medication;
■ on complicated medication regimens;
■ taking medications requiring regular 
monitoring;
■ having difficulty with compliance;
■ showing signs of potential drug-induced 
problems or interactions;
■ not showing the expected response to 
their medication;
■ living alone and having a history of 
cognitive impairment or difficulty with 
vision or hearing;
■ recently hospitalised;
■ considered by a general practitioner or 
other medical professional as likely to 
benefit from the service.
MJA Vol 177 19 August 2002 191
MEDICINE AND THE COMMUNITY
Medication-related problems
Pharmacists identified 2764 medica-
tion-related problems, the most com-
mon (17.5%) being the need for
additional tests (Box 3). On average, 2.5
problems were identified per person.
Thirty-seven per cent of all problems
related to medicine selection, 20% to
patient knowledge and skills, and 17% to
the medication regimen. Only 1% of
problems related to drug–drug interac-
tions, 2% to contraindicated therapy, 2%
to the use of medicine without indica-
tion, and 1% to duplication of therapy.
In response to the identified prob-
lems, pharmacists recommended 2764
actions to GPs, of which 1163 (42%)
were documented in patient case notes
as having been implemented. No infor-
mation was available on implementation
of the remaining actions. This may
mean that no action was taken, that the
action was rejected by the GP, that
follow-up had not occurred at the time
of the study’s completion, or that the
action had been previously trialled, was
still under consideration or was imple-
mented but poorly documented. The
types of actions most commonly imple-
mented included changes to medicine
selection; changes to the dose, fre-
quency or duration of therapy; and
patient education (Box 4).
Follow-up data, as recorded in the
patient’s case notes, were available for
978 (84%) of the problems for which an
action was documented as having been
implemented. Problems were docu-
mented as being “resolved” or “well
managed” in 61% of these cases, and
“improving” in a further 20% (Box 5).
Outcome data were available for 85 of
the problems for which no actions were
implemented. In 61 of these cases the
problem was unresolved or worse at
follow-up, with only 13 of the problems
resolved or well managed at follow-up.
The model required GPs and phar-
macists to negotiate actions based on
the pharmacist’s report. In 23 instances
the GP refused to implement the
action(s); in 31 instances, although the
GP and pharmacist agreed on the
action, the patient refused.
DISCUSSION
1.Discussion
Our study showed that a collaborative
medication management service could
be successfully implemented through
Divisions of General Practice and was
acceptable to all participants. The
process employed enabled GPs and
pharmacists to identify people at risk of
medication misadventure and to
resolve many of their medication-
related problems.
Problems relating to medication use
were common. Importantly, outcome
data reveal that the service resulted in
81% of problems being resolved, well








Change medication selection because 
inappropriate/wrong drug being taken
640 (23.2%) 289 (24.9%)
Consider other management options 536 (19.4%) 161 (13.8%)
Adjust dosage regimen 532 (19.2%) 233 (20.0%)
Change medication based on result of a 
recommended test/examination
495 (17.9%) 110 (9.5%)
Provide patient education and training 309 (11.2%) 212 (18.2%)
Assist with equipment/administration aids 171 (6.2%) 80 (6.9%)
Collect/arrange disposal of medication 81 (2.9%) 78 (6.7%)
Total 2764 (100.0%) 1163 (100.0%)




Need for an additional test (eg, serum creatinine and electrolytes) 483 (17.5%)
Need for additional therapy (eg, physiotherapy, podiatry) 142 (5.1%)
Problems related to medicine selection
Need for additional medicine (eg, influenza vaccine, analgesics) 321 (11.6%)
Wrong or inappropriate medicine (eg, NSAIDs where history indicates
allergic reaction or contraindication)
319 (11.5%)
Adverse drug reactions, including drug–drug interactions and allergies
(eg, NSAIDs with ACE inhibitors)
236 (8.5%)
Unnecessary medicine (eg, quinine taken long-term for nocturnal leg
cramps)
153 (5.5%)
Problems related to medication regimen
Dose too low (eg, analgesics) 223 (8.1%)
Dose too high (eg, psycholeptics) 137 (5.0%)
Rationalisation of drug therapy (eg, changing dose administration time
of diuretic to better fit person’s lifestyle)
97 (3.5%)
Problems related to patient knowledge and skills
Poor understanding of disease and/or treatment 197 (7.1%)
Compliance problems 138 (5.0%)
Inappropriate technique (eg, using asthma inhalers) 99 (3.6%)
Lifestyle issues 75 (2.7%)
Anxiety about treatment 43 (1.6%)
Other
Medicines out-of-date 101 (3.7%)
Total 2764 (100.0%)
NSAID=non-steroidal anti-inflammatory drug. ACE=angiotensin-converting enzyme.
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managed or improving at follow-up.
Although the study was restricted to
South Australia, the inclusion of both
rural and urban Divisions improves the
generalisability of the findings.
The nature and extent of medica-
tion-related problems, particularly in
older at-risk people, has been well
described.1,3,8 The establishment of
professional relationships between
GPs and pharmacists,  achieved
through the participatory action
research approach in our study, was
an important element in the success of
the project.
Importantly, our model is compatible
with the Enhanced Primary Care pack-
age,9 which includes case conferencing
as a rebatable item.
There are many opportunities for col-
laboration between GPs and pharma-
cists to improve health outcomes for
consumers. People at high risk of medi-
cation misadventure include those living
in residential aged-care facilities, those
with chronic illnesses (eg, mental health
problems, asthma, diabetes, cardio-
vascular disease), and those returning
home after a stay in hospital.
Based on the evidence presented in
this project, the HMR service, which is
currently being implemented nation-
ally,4 has the potential to improve the
overall management of medicines in
the community and significantly
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Problem resolved (clear statement given in case notes, or self-evident 
that problem no longer exists [eg, vaccination given])
548 (56.0%)
Problem well managed (clear statement in case notes that processes 
have been established to enable patient to manage an identified problem)
48 (4.9%)
Problem improving (case notes indicate some steps have been taken 
to resolve identified problem, but further steps are required to achieve 
optimal management)
200 (20.4%)
Problem unchanged (case notes indicate no change in identified problem) 144 (14.7%)
Problem worse (case notes indicate deterioration in patient’s health) 17 (1.7%)
Resolution has created new problem (case notes indicate that resolution 
of one problem directly leads to another [eg, allergic reaction to 
recommended medication])
7 (0.7%)
Problem being monitored (case notes indicate general practitioner is 
aware of problem and has agreed, as part of the plan, to monitor patient)
14 (1.4%)
Total 978 (100.0%)
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